Treatment

SPI-62_DF2 clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic exploratory (Phase II)
SPI-62 as a Treatment for Adrenocorticotropic Hormone- dependent Cushing’s Syndrome
This study is looking into a new medication called SPI-62 to treat Cushing's Syndrome. It's in an early phase of testing to see how well it works and if it's safe for people living with this condition.
For: Cushing's Syndrome
Bulgaria · Romania